Evolution	B:C0015219
of	O
Fitness	O
Cost	O
-	I:C0243095
Neutral	I:C0243095
Mutant	O
PfCRT	O
Conferring	O
P.	O
falciparum	I:C0032150
4	O
-	I:C0048060
Aminoquinoline	I:C0048060
Drug	O
Resistance	I:C0013203
Is	O
Accompanied	O
by	O
Altered	O
Parasite	O
Metabolism	O
and	O
Digestive	O
Vacuole	I:C1167024
Physiology	O
.	O

Evolution	O
of	O
Fitness	O
Cost	B:C0243095
-	I:C0243095
Neutral	I:C0243095
Mutant	O
PfCRT	O
Conferring	O
P.	O
falciparum	I:C0032150
4	O
-	I:C0048060
Aminoquinoline	I:C0048060
Drug	O
Resistance	I:C0013203
Is	O
Accompanied	O
by	O
Altered	O
Parasite	O
Metabolism	O
and	O
Digestive	O
Vacuole	I:C1167024
Physiology	O
.	O

Evolution	O
of	O
Fitness	O
Cost	O
-	I:C0243095
Neutral	I:C0243095
Mutant	B:C0596988
PfCRT	O
Conferring	O
P.	O
falciparum	I:C0032150
4	O
-	I:C0048060
Aminoquinoline	I:C0048060
Drug	O
Resistance	I:C0013203
Is	O
Accompanied	O
by	O
Altered	O
Parasite	O
Metabolism	O
and	O
Digestive	O
Vacuole	I:C1167024
Physiology	O
.	O

Evolution	O
of	O
Fitness	O
Cost	O
-	I:C0243095
Neutral	I:C0243095
Mutant	O
PfCRT	B:C0962247
Conferring	O
P.	O
falciparum	I:C0032150
4	O
-	I:C0048060
Aminoquinoline	I:C0048060
Drug	O
Resistance	I:C0013203
Is	O
Accompanied	O
by	O
Altered	O
Parasite	O
Metabolism	O
and	O
Digestive	O
Vacuole	I:C1167024
Physiology	O
.	O

Evolution	O
of	O
Fitness	O
Cost	O
-	I:C0243095
Neutral	I:C0243095
Mutant	O
PfCRT	O
Conferring	O
P.	B:C0032150
falciparum	I:C0032150
4	O
-	I:C0048060
Aminoquinoline	I:C0048060
Drug	O
Resistance	I:C0013203
Is	O
Accompanied	O
by	O
Altered	O
Parasite	O
Metabolism	O
and	O
Digestive	O
Vacuole	I:C1167024
Physiology	O
.	O

Evolution	O
of	O
Fitness	O
Cost	O
-	I:C0243095
Neutral	I:C0243095
Mutant	O
PfCRT	O
Conferring	O
P.	O
falciparum	I:C0032150
4	B:C0048060
-	I:C0048060
Aminoquinoline	I:C0048060
Drug	O
Resistance	I:C0013203
Is	O
Accompanied	O
by	O
Altered	O
Parasite	O
Metabolism	O
and	O
Digestive	O
Vacuole	I:C1167024
Physiology	O
.	O

Evolution	O
of	O
Fitness	O
Cost	O
-	I:C0243095
Neutral	I:C0243095
Mutant	O
PfCRT	O
Conferring	O
P.	O
falciparum	I:C0032150
4	O
-	I:C0048060
Aminoquinoline	I:C0048060
Drug	B:C0013203
Resistance	I:C0013203
Is	O
Accompanied	O
by	O
Altered	O
Parasite	O
Metabolism	O
and	O
Digestive	O
Vacuole	I:C1167024
Physiology	O
.	O

Evolution	O
of	O
Fitness	O
Cost	O
-	I:C0243095
Neutral	I:C0243095
Mutant	O
PfCRT	O
Conferring	O
P.	O
falciparum	I:C0032150
4	O
-	I:C0048060
Aminoquinoline	I:C0048060
Drug	O
Resistance	I:C0013203
Is	O
Accompanied	O
by	O
Altered	O
Parasite	B:C0030498
Metabolism	O
and	O
Digestive	O
Vacuole	I:C1167024
Physiology	O
.	O

Evolution	O
of	O
Fitness	O
Cost	O
-	I:C0243095
Neutral	I:C0243095
Mutant	O
PfCRT	O
Conferring	O
P.	O
falciparum	I:C0032150
4	O
-	I:C0048060
Aminoquinoline	I:C0048060
Drug	O
Resistance	I:C0013203
Is	O
Accompanied	O
by	O
Altered	O
Parasite	O
Metabolism	B:C0025519
and	O
Digestive	O
Vacuole	I:C1167024
Physiology	O
.	O

Evolution	O
of	O
Fitness	O
Cost	O
-	I:C0243095
Neutral	I:C0243095
Mutant	O
PfCRT	O
Conferring	O
P.	O
falciparum	I:C0032150
4	O
-	I:C0048060
Aminoquinoline	I:C0048060
Drug	O
Resistance	I:C0013203
Is	O
Accompanied	O
by	O
Altered	O
Parasite	O
Metabolism	O
and	O
Digestive	B:C1167024
Vacuole	I:C1167024
Physiology	O
.	O

Evolution	O
of	O
Fitness	O
Cost	O
-	I:C0243095
Neutral	I:C0243095
Mutant	O
PfCRT	O
Conferring	O
P.	O
falciparum	I:C0032150
4	O
-	I:C0048060
Aminoquinoline	I:C0048060
Drug	O
Resistance	I:C0013203
Is	O
Accompanied	O
by	O
Altered	O
Parasite	O
Metabolism	O
and	O
Digestive	O
Vacuole	I:C1167024
Physiology	B:C0031842
.	O

Southeast	B:C0003983
Asia	I:C0003983
is	O
an	O
epicenter	O
of	O
multidrug	O
-	O
resistant	O
Plasmodium	O
falciparum	I:C0032150
strains	I:C0032150
.	O

Southeast	O
Asia	I:C0003983
is	O
an	O
epicenter	O
of	O
multidrug	O
-	O
resistant	O
Plasmodium	B:C0032150
falciparum	I:C0032150
strains	I:C0032150
.	O

Selective	O
pressures	O
on	O
the	O
subcontinent	O
have	O
recurrently	O
produced	O
several	O
allelic	B:C0002085
variants	O
of	O
parasite	O
drug	O
resistance	I:C0013203
genes	O
,	O
including	O
the	O
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
(	O
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
)	O
.	O

Selective	O
pressures	O
on	O
the	O
subcontinent	O
have	O
recurrently	O
produced	O
several	O
allelic	O
variants	B:C0678941
of	O
parasite	O
drug	O
resistance	I:C0013203
genes	O
,	O
including	O
the	O
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
(	O
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
)	O
.	O

Selective	O
pressures	O
on	O
the	O
subcontinent	O
have	O
recurrently	O
produced	O
several	O
allelic	O
variants	O
of	O
parasite	B:C0030498
drug	O
resistance	I:C0013203
genes	O
,	O
including	O
the	O
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
(	O
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
)	O
.	O

Selective	O
pressures	O
on	O
the	O
subcontinent	O
have	O
recurrently	O
produced	O
several	O
allelic	O
variants	O
of	O
parasite	O
drug	B:C0013203
resistance	I:C0013203
genes	O
,	O
including	O
the	O
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
(	O
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
)	O
.	O

Selective	O
pressures	O
on	O
the	O
subcontinent	O
have	O
recurrently	O
produced	O
several	O
allelic	O
variants	O
of	O
parasite	O
drug	O
resistance	I:C0013203
genes	B:C0017337
,	O
including	O
the	O
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
(	O
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
)	O
.	O

Selective	O
pressures	O
on	O
the	O
subcontinent	O
have	O
recurrently	O
produced	O
several	O
allelic	O
variants	O
of	O
parasite	O
drug	O
resistance	I:C0013203
genes	O
,	O
including	O
the	O
P.	B:C0017337
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
(	O
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
)	O
.	O

Selective	O
pressures	O
on	O
the	O
subcontinent	O
have	O
recurrently	O
produced	O
several	O
allelic	O
variants	O
of	O
parasite	O
drug	O
resistance	I:C0013203
genes	O
,	O
including	O
the	O
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
(	O
P.	B:C0017337
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
)	O
.	O

Despite	O
significant	O
reductions	B:C0441610
in	O
the	O
deployment	O
of	O
the	O
4	O
-	I:C0048060
aminoquinoline	I:C0048060
drug	O
chloroquine	O
(	O
chloroquine	O
)	O
,	O
which	O
selected	O
for	O
the	O
mutant	O
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
alleles	O
that	O
halted	O
chloroquine	O
efficacy	O
decades	O
ago	O
,	O
the	O
parasite	O
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
locus	O
is	O
continuously	O
evolving	O
.	O

Despite	O
significant	O
reductions	O
in	O
the	O
deployment	O
of	O
the	O
4	B:C0048060
-	I:C0048060
aminoquinoline	I:C0048060
drug	O
chloroquine	O
(	O
chloroquine	O
)	O
,	O
which	O
selected	O
for	O
the	O
mutant	O
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
alleles	O
that	O
halted	O
chloroquine	O
efficacy	O
decades	O
ago	O
,	O
the	O
parasite	O
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
locus	O
is	O
continuously	O
evolving	O
.	O

Despite	O
significant	O
reductions	O
in	O
the	O
deployment	O
of	O
the	O
4	O
-	I:C0048060
aminoquinoline	I:C0048060
drug	B:C1254351
chloroquine	O
(	O
chloroquine	O
)	O
,	O
which	O
selected	O
for	O
the	O
mutant	O
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
alleles	O
that	O
halted	O
chloroquine	O
efficacy	O
decades	O
ago	O
,	O
the	O
parasite	O
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
locus	O
is	O
continuously	O
evolving	O
.	O

Despite	O
significant	O
reductions	O
in	O
the	O
deployment	O
of	O
the	O
4	O
-	I:C0048060
aminoquinoline	I:C0048060
drug	O
chloroquine	B:C0008269
(	O
chloroquine	O
)	O
,	O
which	O
selected	O
for	O
the	O
mutant	O
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
alleles	O
that	O
halted	O
chloroquine	O
efficacy	O
decades	O
ago	O
,	O
the	O
parasite	O
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
locus	O
is	O
continuously	O
evolving	O
.	O

Despite	O
significant	O
reductions	O
in	O
the	O
deployment	O
of	O
the	O
4	O
-	I:C0048060
aminoquinoline	I:C0048060
drug	O
chloroquine	O
(	O
chloroquine	B:C0008269
)	O
,	O
which	O
selected	O
for	O
the	O
mutant	O
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
alleles	O
that	O
halted	O
chloroquine	O
efficacy	O
decades	O
ago	O
,	O
the	O
parasite	O
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
locus	O
is	O
continuously	O
evolving	O
.	O

Despite	O
significant	O
reductions	O
in	O
the	O
deployment	O
of	O
the	O
4	O
-	I:C0048060
aminoquinoline	I:C0048060
drug	O
chloroquine	O
(	O
chloroquine	O
)	O
,	O
which	O
selected	O
for	O
the	O
mutant	B:C0678941
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
alleles	O
that	O
halted	O
chloroquine	O
efficacy	O
decades	O
ago	O
,	O
the	O
parasite	O
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
locus	O
is	O
continuously	O
evolving	O
.	O

Despite	O
significant	O
reductions	O
in	O
the	O
deployment	O
of	O
the	O
4	O
-	I:C0048060
aminoquinoline	I:C0048060
drug	O
chloroquine	O
(	O
chloroquine	O
)	O
,	O
which	O
selected	O
for	O
the	O
mutant	O
P.	B:C0017337
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
alleles	O
that	O
halted	O
chloroquine	O
efficacy	O
decades	O
ago	O
,	O
the	O
parasite	O
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
locus	O
is	O
continuously	O
evolving	O
.	O

Despite	O
significant	O
reductions	O
in	O
the	O
deployment	O
of	O
the	O
4	O
-	I:C0048060
aminoquinoline	I:C0048060
drug	O
chloroquine	O
(	O
chloroquine	O
)	O
,	O
which	O
selected	O
for	O
the	O
mutant	O
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
alleles	B:C0002085
that	O
halted	O
chloroquine	O
efficacy	O
decades	O
ago	O
,	O
the	O
parasite	O
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
locus	O
is	O
continuously	O
evolving	O
.	O

Despite	O
significant	O
reductions	O
in	O
the	O
deployment	O
of	O
the	O
4	O
-	I:C0048060
aminoquinoline	I:C0048060
drug	O
chloroquine	O
(	O
chloroquine	O
)	O
,	O
which	O
selected	O
for	O
the	O
mutant	O
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
alleles	O
that	O
halted	O
chloroquine	B:C0008269
efficacy	O
decades	O
ago	O
,	O
the	O
parasite	O
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
locus	O
is	O
continuously	O
evolving	O
.	O

Despite	O
significant	O
reductions	O
in	O
the	O
deployment	O
of	O
the	O
4	O
-	I:C0048060
aminoquinoline	I:C0048060
drug	O
chloroquine	O
(	O
chloroquine	O
)	O
,	O
which	O
selected	O
for	O
the	O
mutant	O
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
alleles	O
that	O
halted	O
chloroquine	O
efficacy	O
decades	O
ago	O
,	O
the	O
parasite	B:C0030498
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
locus	O
is	O
continuously	O
evolving	O
.	O

Despite	O
significant	O
reductions	O
in	O
the	O
deployment	O
of	O
the	O
4	O
-	I:C0048060
aminoquinoline	I:C0048060
drug	O
chloroquine	O
(	O
chloroquine	O
)	O
,	O
which	O
selected	O
for	O
the	O
mutant	O
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
alleles	O
that	O
halted	O
chloroquine	O
efficacy	O
decades	O
ago	O
,	O
the	O
parasite	O
P.	B:C0017337
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
locus	O
is	O
continuously	O
evolving	O
.	O

Despite	O
significant	O
reductions	O
in	O
the	O
deployment	O
of	O
the	O
4	O
-	I:C0048060
aminoquinoline	I:C0048060
drug	O
chloroquine	O
(	O
chloroquine	O
)	O
,	O
which	O
selected	O
for	O
the	O
mutant	O
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
alleles	O
that	O
halted	O
chloroquine	O
efficacy	O
decades	O
ago	O
,	O
the	O
parasite	O
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
locus	B:C1708726
is	O
continuously	O
evolving	O
.	O

This	O
is	O
highlighted	O
by	O
the	O
presence	O
of	O
a	O
highly	O
mutated	B:C0026882
allele	O
,	O
Cam734	O
pfcrt	I:C0017337
,	O
which	O
has	O
acquired	O
the	O
singular	O
ability	O
to	O
confer	O
parasite	O
chloroquine	O
resistance	O
without	O
an	O
associated	O
fitness	O
cost	O
.	O

This	O
is	O
highlighted	O
by	O
the	O
presence	O
of	O
a	O
highly	O
mutated	O
allele	B:C0002085
,	O
Cam734	O
pfcrt	I:C0017337
,	O
which	O
has	O
acquired	O
the	O
singular	O
ability	O
to	O
confer	O
parasite	O
chloroquine	O
resistance	O
without	O
an	O
associated	O
fitness	O
cost	O
.	O

This	O
is	O
highlighted	O
by	O
the	O
presence	O
of	O
a	O
highly	O
mutated	O
allele	O
,	O
Cam734	B:C0017337
pfcrt	I:C0017337
,	O
which	O
has	O
acquired	O
the	O
singular	O
ability	O
to	O
confer	O
parasite	O
chloroquine	O
resistance	O
without	O
an	O
associated	O
fitness	O
cost	O
.	O

This	O
is	O
highlighted	O
by	O
the	O
presence	O
of	O
a	O
highly	O
mutated	O
allele	O
,	O
Cam734	O
pfcrt	I:C0017337
,	O
which	O
has	O
acquired	O
the	O
singular	O
ability	O
to	O
confer	O
parasite	B:C0030498
chloroquine	O
resistance	O
without	O
an	O
associated	O
fitness	O
cost	O
.	O

This	O
is	O
highlighted	O
by	O
the	O
presence	O
of	O
a	O
highly	O
mutated	O
allele	O
,	O
Cam734	O
pfcrt	I:C0017337
,	O
which	O
has	O
acquired	O
the	O
singular	O
ability	O
to	O
confer	O
parasite	O
chloroquine	B:C0008269
resistance	O
without	O
an	O
associated	O
fitness	O
cost	O
.	O

This	O
is	O
highlighted	O
by	O
the	O
presence	O
of	O
a	O
highly	O
mutated	O
allele	O
,	O
Cam734	O
pfcrt	I:C0017337
,	O
which	O
has	O
acquired	O
the	O
singular	O
ability	O
to	O
confer	O
parasite	O
chloroquine	O
resistance	B:C0013203
without	O
an	O
associated	O
fitness	O
cost	O
.	O

Here	O
,	O
we	O
used	O
P.	B:C0017337
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
-	O
specific	O
zinc	O
-	I:C0597094
finger	I:C0597094
nucleases	I:C0597094
to	O
genetically	O
dissect	O
this	O
allele	O
in	O
the	O
pathogenic	O
setting	O
of	O
asexual	O
blood	I:C3714514
-	I:C3714514
stage	I:C3714514
infection	I:C3714514
.	O

Here	O
,	O
we	O
used	O
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
-	O
specific	O
zinc	B:C0597094
-	I:C0597094
finger	I:C0597094
nucleases	I:C0597094
to	O
genetically	O
dissect	O
this	O
allele	O
in	O
the	O
pathogenic	O
setting	O
of	O
asexual	O
blood	I:C3714514
-	I:C3714514
stage	I:C3714514
infection	I:C3714514
.	O

Here	O
,	O
we	O
used	O
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
-	O
specific	O
zinc	O
-	I:C0597094
finger	I:C0597094
nucleases	I:C0597094
to	O
genetically	O
dissect	O
this	O
allele	B:C0002085
in	O
the	O
pathogenic	O
setting	O
of	O
asexual	O
blood	I:C3714514
-	I:C3714514
stage	I:C3714514
infection	I:C3714514
.	O

Here	O
,	O
we	O
used	O
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
-	O
specific	O
zinc	O
-	I:C0597094
finger	I:C0597094
nucleases	I:C0597094
to	O
genetically	O
dissect	O
this	O
allele	O
in	O
the	O
pathogenic	B:C3816499
setting	O
of	O
asexual	O
blood	I:C3714514
-	I:C3714514
stage	I:C3714514
infection	I:C3714514
.	O

Here	O
,	O
we	O
used	O
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
-	O
specific	O
zinc	O
-	I:C0597094
finger	I:C0597094
nucleases	I:C0597094
to	O
genetically	O
dissect	O
this	O
allele	O
in	O
the	O
pathogenic	O
setting	O
of	O
asexual	B:C3714514
blood	I:C3714514
-	I:C3714514
stage	I:C3714514
infection	I:C3714514
.	O

Comparative	O
analysis	O
of	O
drug	B:C0013203
resistance	I:C0013203
and	O
growth	O
profiles	O
of	O
recombinant	O
parasites	I:C0030498
that	O
express	O
Cam734	O
or	O
variants	O
thereof	O
,	O
Dd2	O
(	O
the	O
most	O
common	O
Southeast	O
Asian	I:C0003983
variant	O
)	O
,	O
or	O
wild	O
-	I:C1883559
type	I:C1883559
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
,	O
revealed	O
previously	O
unknown	O
roles	O
for	O
PfCRT	O
mutations	O
in	O
modulating	O
parasite	O
susceptibility	O
to	O
multiple	O
antimalarial	O
agents	I:C0003374
.	O

Comparative	O
analysis	O
of	O
drug	O
resistance	I:C0013203
and	O
growth	B:C0018270
profiles	O
of	O
recombinant	O
parasites	I:C0030498
that	O
express	O
Cam734	O
or	O
variants	O
thereof	O
,	O
Dd2	O
(	O
the	O
most	O
common	O
Southeast	O
Asian	I:C0003983
variant	O
)	O
,	O
or	O
wild	O
-	I:C1883559
type	I:C1883559
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
,	O
revealed	O
previously	O
unknown	O
roles	O
for	O
PfCRT	O
mutations	O
in	O
modulating	O
parasite	O
susceptibility	O
to	O
multiple	O
antimalarial	O
agents	I:C0003374
.	O

Comparative	O
analysis	O
of	O
drug	O
resistance	I:C0013203
and	O
growth	O
profiles	O
of	O
recombinant	B:C0030498
parasites	I:C0030498
that	O
express	O
Cam734	O
or	O
variants	O
thereof	O
,	O
Dd2	O
(	O
the	O
most	O
common	O
Southeast	O
Asian	I:C0003983
variant	O
)	O
,	O
or	O
wild	O
-	I:C1883559
type	I:C1883559
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
,	O
revealed	O
previously	O
unknown	O
roles	O
for	O
PfCRT	O
mutations	O
in	O
modulating	O
parasite	O
susceptibility	O
to	O
multiple	O
antimalarial	O
agents	I:C0003374
.	O

Comparative	O
analysis	O
of	O
drug	O
resistance	I:C0013203
and	O
growth	O
profiles	O
of	O
recombinant	O
parasites	I:C0030498
that	O
express	B:C0017262
Cam734	O
or	O
variants	O
thereof	O
,	O
Dd2	O
(	O
the	O
most	O
common	O
Southeast	O
Asian	I:C0003983
variant	O
)	O
,	O
or	O
wild	O
-	I:C1883559
type	I:C1883559
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
,	O
revealed	O
previously	O
unknown	O
roles	O
for	O
PfCRT	O
mutations	O
in	O
modulating	O
parasite	O
susceptibility	O
to	O
multiple	O
antimalarial	O
agents	I:C0003374
.	O

Comparative	O
analysis	O
of	O
drug	O
resistance	I:C0013203
and	O
growth	O
profiles	O
of	O
recombinant	O
parasites	I:C0030498
that	O
express	O
Cam734	B:C0017337
or	O
variants	O
thereof	O
,	O
Dd2	O
(	O
the	O
most	O
common	O
Southeast	O
Asian	I:C0003983
variant	O
)	O
,	O
or	O
wild	O
-	I:C1883559
type	I:C1883559
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
,	O
revealed	O
previously	O
unknown	O
roles	O
for	O
PfCRT	O
mutations	O
in	O
modulating	O
parasite	O
susceptibility	O
to	O
multiple	O
antimalarial	O
agents	I:C0003374
.	O

Comparative	O
analysis	O
of	O
drug	O
resistance	I:C0013203
and	O
growth	O
profiles	O
of	O
recombinant	O
parasites	I:C0030498
that	O
express	O
Cam734	O
or	O
variants	B:C0678941
thereof	O
,	O
Dd2	O
(	O
the	O
most	O
common	O
Southeast	O
Asian	I:C0003983
variant	O
)	O
,	O
or	O
wild	O
-	I:C1883559
type	I:C1883559
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
,	O
revealed	O
previously	O
unknown	O
roles	O
for	O
PfCRT	O
mutations	O
in	O
modulating	O
parasite	O
susceptibility	O
to	O
multiple	O
antimalarial	O
agents	I:C0003374
.	O

Comparative	O
analysis	O
of	O
drug	O
resistance	I:C0013203
and	O
growth	O
profiles	O
of	O
recombinant	O
parasites	I:C0030498
that	O
express	O
Cam734	O
or	O
variants	O
thereof	O
,	O
Dd2	B:C0017337
(	O
the	O
most	O
common	O
Southeast	O
Asian	I:C0003983
variant	O
)	O
,	O
or	O
wild	O
-	I:C1883559
type	I:C1883559
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
,	O
revealed	O
previously	O
unknown	O
roles	O
for	O
PfCRT	O
mutations	O
in	O
modulating	O
parasite	O
susceptibility	O
to	O
multiple	O
antimalarial	O
agents	I:C0003374
.	O

Comparative	O
analysis	O
of	O
drug	O
resistance	I:C0013203
and	O
growth	O
profiles	O
of	O
recombinant	O
parasites	I:C0030498
that	O
express	O
Cam734	O
or	O
variants	O
thereof	O
,	O
Dd2	O
(	O
the	O
most	O
common	O
Southeast	B:C0003983
Asian	I:C0003983
variant	O
)	O
,	O
or	O
wild	O
-	I:C1883559
type	I:C1883559
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
,	O
revealed	O
previously	O
unknown	O
roles	O
for	O
PfCRT	O
mutations	O
in	O
modulating	O
parasite	O
susceptibility	O
to	O
multiple	O
antimalarial	O
agents	I:C0003374
.	O

Comparative	O
analysis	O
of	O
drug	O
resistance	I:C0013203
and	O
growth	O
profiles	O
of	O
recombinant	O
parasites	I:C0030498
that	O
express	O
Cam734	O
or	O
variants	O
thereof	O
,	O
Dd2	O
(	O
the	O
most	O
common	O
Southeast	O
Asian	I:C0003983
variant	B:C0678941
)	O
,	O
or	O
wild	O
-	I:C1883559
type	I:C1883559
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
,	O
revealed	O
previously	O
unknown	O
roles	O
for	O
PfCRT	O
mutations	O
in	O
modulating	O
parasite	O
susceptibility	O
to	O
multiple	O
antimalarial	O
agents	I:C0003374
.	O

Comparative	O
analysis	O
of	O
drug	O
resistance	I:C0013203
and	O
growth	O
profiles	O
of	O
recombinant	O
parasites	I:C0030498
that	O
express	O
Cam734	O
or	O
variants	O
thereof	O
,	O
Dd2	O
(	O
the	O
most	O
common	O
Southeast	O
Asian	I:C0003983
variant	O
)	O
,	O
or	O
wild	B:C1883559
-	I:C1883559
type	I:C1883559
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
,	O
revealed	O
previously	O
unknown	O
roles	O
for	O
PfCRT	O
mutations	O
in	O
modulating	O
parasite	O
susceptibility	O
to	O
multiple	O
antimalarial	O
agents	I:C0003374
.	O

Comparative	O
analysis	O
of	O
drug	O
resistance	I:C0013203
and	O
growth	O
profiles	O
of	O
recombinant	O
parasites	I:C0030498
that	O
express	O
Cam734	O
or	O
variants	O
thereof	O
,	O
Dd2	O
(	O
the	O
most	O
common	O
Southeast	O
Asian	I:C0003983
variant	O
)	O
,	O
or	O
wild	O
-	I:C1883559
type	I:C1883559
P.	B:C0017337
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
,	O
revealed	O
previously	O
unknown	O
roles	O
for	O
PfCRT	O
mutations	O
in	O
modulating	O
parasite	O
susceptibility	O
to	O
multiple	O
antimalarial	O
agents	I:C0003374
.	O

Comparative	O
analysis	O
of	O
drug	O
resistance	I:C0013203
and	O
growth	O
profiles	O
of	O
recombinant	O
parasites	I:C0030498
that	O
express	O
Cam734	O
or	O
variants	O
thereof	O
,	O
Dd2	O
(	O
the	O
most	O
common	O
Southeast	O
Asian	I:C0003983
variant	O
)	O
,	O
or	O
wild	O
-	I:C1883559
type	I:C1883559
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
,	O
revealed	O
previously	O
unknown	O
roles	O
for	O
PfCRT	B:C0962247
mutations	O
in	O
modulating	O
parasite	O
susceptibility	O
to	O
multiple	O
antimalarial	O
agents	I:C0003374
.	O

Comparative	O
analysis	O
of	O
drug	O
resistance	I:C0013203
and	O
growth	O
profiles	O
of	O
recombinant	O
parasites	I:C0030498
that	O
express	O
Cam734	O
or	O
variants	O
thereof	O
,	O
Dd2	O
(	O
the	O
most	O
common	O
Southeast	O
Asian	I:C0003983
variant	O
)	O
,	O
or	O
wild	O
-	I:C1883559
type	I:C1883559
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
,	O
revealed	O
previously	O
unknown	O
roles	O
for	O
PfCRT	O
mutations	B:C0026882
in	O
modulating	O
parasite	O
susceptibility	O
to	O
multiple	O
antimalarial	O
agents	I:C0003374
.	O

Comparative	O
analysis	O
of	O
drug	O
resistance	I:C0013203
and	O
growth	O
profiles	O
of	O
recombinant	O
parasites	I:C0030498
that	O
express	O
Cam734	O
or	O
variants	O
thereof	O
,	O
Dd2	O
(	O
the	O
most	O
common	O
Southeast	O
Asian	I:C0003983
variant	O
)	O
,	O
or	O
wild	O
-	I:C1883559
type	I:C1883559
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
,	O
revealed	O
previously	O
unknown	O
roles	O
for	O
PfCRT	O
mutations	O
in	O
modulating	O
parasite	B:C0030498
susceptibility	O
to	O
multiple	O
antimalarial	O
agents	I:C0003374
.	O

Comparative	O
analysis	O
of	O
drug	O
resistance	I:C0013203
and	O
growth	O
profiles	O
of	O
recombinant	O
parasites	I:C0030498
that	O
express	O
Cam734	O
or	O
variants	O
thereof	O
,	O
Dd2	O
(	O
the	O
most	O
common	O
Southeast	O
Asian	I:C0003983
variant	O
)	O
,	O
or	O
wild	O
-	I:C1883559
type	I:C1883559
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
,	O
revealed	O
previously	O
unknown	O
roles	O
for	O
PfCRT	O
mutations	O
in	O
modulating	O
parasite	O
susceptibility	O
to	O
multiple	O
antimalarial	B:C0003374
agents	I:C0003374
.	O

These	O
results	O
were	O
generated	O
in	O
the	O
GC03	B:C0017337
strain	O
,	O
used	O
in	O
multiple	O
earlier	O
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
studies	O
,	O
and	O
might	O
differ	O
in	O
natural	O
isolates	O
harboring	O
this	O
allele	O
.	O

These	O
results	O
were	O
generated	O
in	O
the	O
GC03	O
strain	O
,	O
used	O
in	O
multiple	O
earlier	O
P.	B:C0017337
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
studies	O
,	O
and	O
might	O
differ	O
in	O
natural	O
isolates	O
harboring	O
this	O
allele	O
.	O

These	O
results	O
were	O
generated	O
in	O
the	O
GC03	O
strain	O
,	O
used	O
in	O
multiple	O
earlier	O
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
studies	B:C2603343
,	O
and	O
might	O
differ	O
in	O
natural	O
isolates	O
harboring	O
this	O
allele	O
.	O

These	O
results	O
were	O
generated	O
in	O
the	O
GC03	O
strain	O
,	O
used	O
in	O
multiple	O
earlier	O
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
studies	O
,	O
and	O
might	O
differ	O
in	O
natural	O
isolates	O
harboring	O
this	O
allele	B:C0002085
.	O

Results	O
presented	O
herein	O
show	O
that	O
Cam734	B:C0017337
-	O
mediated	O
chloroquine	O
resistance	O
is	O
dependent	O
on	O
the	O
rare	O
A144	O
F	I:C0026882
mutation	O
that	O
has	O
not	O
been	O
observed	O
beyond	O
Southeast	O
Asia	I:C0003983
,	O
and	O
reveal	O
distinct	O
impacts	O
of	O
this	O
and	O
other	O
Cam734	O
-	O
specific	O
mutations	O
on	O
chloroquine	O
resistance	O
and	O
parasite	O
growth	O
rates	O
.	O

Results	O
presented	O
herein	O
show	O
that	O
Cam734	O
-	O
mediated	O
chloroquine	B:C0008269
resistance	O
is	O
dependent	O
on	O
the	O
rare	O
A144	O
F	I:C0026882
mutation	O
that	O
has	O
not	O
been	O
observed	O
beyond	O
Southeast	O
Asia	I:C0003983
,	O
and	O
reveal	O
distinct	O
impacts	O
of	O
this	O
and	O
other	O
Cam734	O
-	O
specific	O
mutations	O
on	O
chloroquine	O
resistance	O
and	O
parasite	O
growth	O
rates	O
.	O

Results	O
presented	O
herein	O
show	O
that	O
Cam734	O
-	O
mediated	O
chloroquine	O
resistance	B:C0013203
is	O
dependent	O
on	O
the	O
rare	O
A144	O
F	I:C0026882
mutation	O
that	O
has	O
not	O
been	O
observed	O
beyond	O
Southeast	O
Asia	I:C0003983
,	O
and	O
reveal	O
distinct	O
impacts	O
of	O
this	O
and	O
other	O
Cam734	O
-	O
specific	O
mutations	O
on	O
chloroquine	O
resistance	O
and	O
parasite	O
growth	O
rates	O
.	O

Results	O
presented	O
herein	O
show	O
that	O
Cam734	O
-	O
mediated	O
chloroquine	O
resistance	O
is	O
dependent	O
on	O
the	O
rare	O
A144	B:C0026882
F	I:C0026882
mutation	O
that	O
has	O
not	O
been	O
observed	O
beyond	O
Southeast	O
Asia	I:C0003983
,	O
and	O
reveal	O
distinct	O
impacts	O
of	O
this	O
and	O
other	O
Cam734	O
-	O
specific	O
mutations	O
on	O
chloroquine	O
resistance	O
and	O
parasite	O
growth	O
rates	O
.	O

Results	O
presented	O
herein	O
show	O
that	O
Cam734	O
-	O
mediated	O
chloroquine	O
resistance	O
is	O
dependent	O
on	O
the	O
rare	O
A144	O
F	I:C0026882
mutation	B:C0026882
that	O
has	O
not	O
been	O
observed	O
beyond	O
Southeast	O
Asia	I:C0003983
,	O
and	O
reveal	O
distinct	O
impacts	O
of	O
this	O
and	O
other	O
Cam734	O
-	O
specific	O
mutations	O
on	O
chloroquine	O
resistance	O
and	O
parasite	O
growth	O
rates	O
.	O

Results	O
presented	O
herein	O
show	O
that	O
Cam734	O
-	O
mediated	O
chloroquine	O
resistance	O
is	O
dependent	O
on	O
the	O
rare	O
A144	O
F	I:C0026882
mutation	O
that	O
has	O
not	O
been	O
observed	O
beyond	O
Southeast	B:C0003983
Asia	I:C0003983
,	O
and	O
reveal	O
distinct	O
impacts	O
of	O
this	O
and	O
other	O
Cam734	O
-	O
specific	O
mutations	O
on	O
chloroquine	O
resistance	O
and	O
parasite	O
growth	O
rates	O
.	O

Results	O
presented	O
herein	O
show	O
that	O
Cam734	O
-	O
mediated	O
chloroquine	O
resistance	O
is	O
dependent	O
on	O
the	O
rare	O
A144	O
F	I:C0026882
mutation	O
that	O
has	O
not	O
been	O
observed	O
beyond	O
Southeast	O
Asia	I:C0003983
,	O
and	O
reveal	O
distinct	O
impacts	O
of	O
this	O
and	O
other	O
Cam734	B:C0017337
-	O
specific	O
mutations	O
on	O
chloroquine	O
resistance	O
and	O
parasite	O
growth	O
rates	O
.	O

Results	O
presented	O
herein	O
show	O
that	O
Cam734	O
-	O
mediated	O
chloroquine	O
resistance	O
is	O
dependent	O
on	O
the	O
rare	O
A144	O
F	I:C0026882
mutation	O
that	O
has	O
not	O
been	O
observed	O
beyond	O
Southeast	O
Asia	I:C0003983
,	O
and	O
reveal	O
distinct	O
impacts	O
of	O
this	O
and	O
other	O
Cam734	O
-	O
specific	O
mutations	B:C0026882
on	O
chloroquine	O
resistance	O
and	O
parasite	O
growth	O
rates	O
.	O

Results	O
presented	O
herein	O
show	O
that	O
Cam734	O
-	O
mediated	O
chloroquine	O
resistance	O
is	O
dependent	O
on	O
the	O
rare	O
A144	O
F	I:C0026882
mutation	O
that	O
has	O
not	O
been	O
observed	O
beyond	O
Southeast	O
Asia	I:C0003983
,	O
and	O
reveal	O
distinct	O
impacts	O
of	O
this	O
and	O
other	O
Cam734	O
-	O
specific	O
mutations	O
on	O
chloroquine	B:C0008269
resistance	O
and	O
parasite	O
growth	O
rates	O
.	O

Results	O
presented	O
herein	O
show	O
that	O
Cam734	O
-	O
mediated	O
chloroquine	O
resistance	O
is	O
dependent	O
on	O
the	O
rare	O
A144	O
F	I:C0026882
mutation	O
that	O
has	O
not	O
been	O
observed	O
beyond	O
Southeast	O
Asia	I:C0003983
,	O
and	O
reveal	O
distinct	O
impacts	O
of	O
this	O
and	O
other	O
Cam734	O
-	O
specific	O
mutations	O
on	O
chloroquine	O
resistance	B:C0013203
and	O
parasite	O
growth	O
rates	O
.	O

Results	O
presented	O
herein	O
show	O
that	O
Cam734	O
-	O
mediated	O
chloroquine	O
resistance	O
is	O
dependent	O
on	O
the	O
rare	O
A144	O
F	I:C0026882
mutation	O
that	O
has	O
not	O
been	O
observed	O
beyond	O
Southeast	O
Asia	I:C0003983
,	O
and	O
reveal	O
distinct	O
impacts	O
of	O
this	O
and	O
other	O
Cam734	O
-	O
specific	O
mutations	O
on	O
chloroquine	O
resistance	O
and	O
parasite	B:C0030498
growth	O
rates	O
.	O

Biochemical	B:C0005507
assays	I:C0005507
revealed	O
a	O
broad	O
impact	O
of	O
mutant	O
PfCRT	O
isoforms	O
on	O
parasite	O
metabolism	O
,	O
including	O
nucleoside	O
triphosphate	O
levels	O
,	O
hemoglobin	O
catabolism	I:C1157963
and	O
disposition	O
of	O
heme	O
,	O
as	O
well	O
as	O
digestive	O
vacuole	I:C1167024
volume	O
and	O
pH	O
.	O

Biochemical	O
assays	I:C0005507
revealed	O
a	O
broad	O
impact	O
of	O
mutant	B:C0596988
PfCRT	O
isoforms	O
on	O
parasite	O
metabolism	O
,	O
including	O
nucleoside	O
triphosphate	O
levels	O
,	O
hemoglobin	O
catabolism	I:C1157963
and	O
disposition	O
of	O
heme	O
,	O
as	O
well	O
as	O
digestive	O
vacuole	I:C1167024
volume	O
and	O
pH	O
.	O

Biochemical	O
assays	I:C0005507
revealed	O
a	O
broad	O
impact	O
of	O
mutant	O
PfCRT	B:C0962247
isoforms	O
on	O
parasite	O
metabolism	O
,	O
including	O
nucleoside	O
triphosphate	O
levels	O
,	O
hemoglobin	O
catabolism	I:C1157963
and	O
disposition	O
of	O
heme	O
,	O
as	O
well	O
as	O
digestive	O
vacuole	I:C1167024
volume	O
and	O
pH	O
.	O

Biochemical	O
assays	I:C0005507
revealed	O
a	O
broad	O
impact	O
of	O
mutant	O
PfCRT	O
isoforms	B:C0597298
on	O
parasite	O
metabolism	O
,	O
including	O
nucleoside	O
triphosphate	O
levels	O
,	O
hemoglobin	O
catabolism	I:C1157963
and	O
disposition	O
of	O
heme	O
,	O
as	O
well	O
as	O
digestive	O
vacuole	I:C1167024
volume	O
and	O
pH	O
.	O

Biochemical	O
assays	I:C0005507
revealed	O
a	O
broad	O
impact	O
of	O
mutant	O
PfCRT	O
isoforms	O
on	O
parasite	B:C0030498
metabolism	O
,	O
including	O
nucleoside	O
triphosphate	O
levels	O
,	O
hemoglobin	O
catabolism	I:C1157963
and	O
disposition	O
of	O
heme	O
,	O
as	O
well	O
as	O
digestive	O
vacuole	I:C1167024
volume	O
and	O
pH	O
.	O

Biochemical	O
assays	I:C0005507
revealed	O
a	O
broad	O
impact	O
of	O
mutant	O
PfCRT	O
isoforms	O
on	O
parasite	O
metabolism	B:C0025519
,	O
including	O
nucleoside	O
triphosphate	O
levels	O
,	O
hemoglobin	O
catabolism	I:C1157963
and	O
disposition	O
of	O
heme	O
,	O
as	O
well	O
as	O
digestive	O
vacuole	I:C1167024
volume	O
and	O
pH	O
.	O

Biochemical	O
assays	I:C0005507
revealed	O
a	O
broad	O
impact	O
of	O
mutant	O
PfCRT	O
isoforms	O
on	O
parasite	O
metabolism	O
,	O
including	O
nucleoside	O
triphosphate	O
levels	O
,	O
hemoglobin	B:C1157963
catabolism	I:C1157963
and	O
disposition	O
of	O
heme	O
,	O
as	O
well	O
as	O
digestive	O
vacuole	I:C1167024
volume	O
and	O
pH	O
.	O

Biochemical	O
assays	I:C0005507
revealed	O
a	O
broad	O
impact	O
of	O
mutant	O
PfCRT	O
isoforms	O
on	O
parasite	O
metabolism	O
,	O
including	O
nucleoside	O
triphosphate	O
levels	O
,	O
hemoglobin	O
catabolism	I:C1157963
and	O
disposition	O
of	O
heme	B:C0018966
,	O
as	O
well	O
as	O
digestive	O
vacuole	I:C1167024
volume	O
and	O
pH	O
.	O

Biochemical	O
assays	I:C0005507
revealed	O
a	O
broad	O
impact	O
of	O
mutant	O
PfCRT	O
isoforms	O
on	O
parasite	O
metabolism	O
,	O
including	O
nucleoside	O
triphosphate	O
levels	O
,	O
hemoglobin	O
catabolism	I:C1157963
and	O
disposition	O
of	O
heme	O
,	O
as	O
well	O
as	O
digestive	B:C1167024
vacuole	I:C1167024
volume	O
and	O
pH	O
.	O

Results	O
from	O
our	O
study	O
provide	O
new	O
insights	O
into	O
the	O
complex	B:C4246449
molecular	I:C4246449
basis	I:C4246449
and	O
physiological	O
impact	O
of	O
PfCRT	O
-	O
mediated	O
antimalarial	O
drug	O
resistance	I:C0013203
,	O
and	O
inform	O
ongoing	O
efforts	O
to	O
characterize	O
novel	O
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
alleles	O
that	O
can	O
undermine	O
the	O
efficacy	O
of	O
first	O
-	O
line	O
antimalarial	O
drug	I:C0003374
regimens	O
.	O

Results	O
from	O
our	O
study	O
provide	O
new	O
insights	O
into	O
the	O
complex	O
molecular	I:C4246449
basis	I:C4246449
and	O
physiological	O
impact	O
of	O
PfCRT	B:C0962247
-	O
mediated	O
antimalarial	O
drug	O
resistance	I:C0013203
,	O
and	O
inform	O
ongoing	O
efforts	O
to	O
characterize	O
novel	O
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
alleles	O
that	O
can	O
undermine	O
the	O
efficacy	O
of	O
first	O
-	O
line	O
antimalarial	O
drug	I:C0003374
regimens	O
.	O

Results	O
from	O
our	O
study	O
provide	O
new	O
insights	O
into	O
the	O
complex	O
molecular	I:C4246449
basis	I:C4246449
and	O
physiological	O
impact	O
of	O
PfCRT	O
-	O
mediated	O
antimalarial	B:C0003374
drug	O
resistance	I:C0013203
,	O
and	O
inform	O
ongoing	O
efforts	O
to	O
characterize	O
novel	O
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
alleles	O
that	O
can	O
undermine	O
the	O
efficacy	O
of	O
first	O
-	O
line	O
antimalarial	O
drug	I:C0003374
regimens	O
.	O

Results	O
from	O
our	O
study	O
provide	O
new	O
insights	O
into	O
the	O
complex	O
molecular	I:C4246449
basis	I:C4246449
and	O
physiological	O
impact	O
of	O
PfCRT	O
-	O
mediated	O
antimalarial	O
drug	B:C0013203
resistance	I:C0013203
,	O
and	O
inform	O
ongoing	O
efforts	O
to	O
characterize	O
novel	O
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
alleles	O
that	O
can	O
undermine	O
the	O
efficacy	O
of	O
first	O
-	O
line	O
antimalarial	O
drug	I:C0003374
regimens	O
.	O

Results	O
from	O
our	O
study	O
provide	O
new	O
insights	O
into	O
the	O
complex	O
molecular	I:C4246449
basis	I:C4246449
and	O
physiological	O
impact	O
of	O
PfCRT	O
-	O
mediated	O
antimalarial	O
drug	O
resistance	I:C0013203
,	O
and	O
inform	O
ongoing	O
efforts	O
to	O
characterize	O
novel	O
P.	B:C0017337
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
alleles	O
that	O
can	O
undermine	O
the	O
efficacy	O
of	O
first	O
-	O
line	O
antimalarial	O
drug	I:C0003374
regimens	O
.	O

Results	O
from	O
our	O
study	O
provide	O
new	O
insights	O
into	O
the	O
complex	O
molecular	I:C4246449
basis	I:C4246449
and	O
physiological	O
impact	O
of	O
PfCRT	O
-	O
mediated	O
antimalarial	O
drug	O
resistance	I:C0013203
,	O
and	O
inform	O
ongoing	O
efforts	O
to	O
characterize	O
novel	O
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
alleles	B:C0002085
that	O
can	O
undermine	O
the	O
efficacy	O
of	O
first	O
-	O
line	O
antimalarial	O
drug	I:C0003374
regimens	O
.	O

Results	O
from	O
our	O
study	O
provide	O
new	O
insights	O
into	O
the	O
complex	O
molecular	I:C4246449
basis	I:C4246449
and	O
physiological	O
impact	O
of	O
PfCRT	O
-	O
mediated	O
antimalarial	O
drug	O
resistance	I:C0013203
,	O
and	O
inform	O
ongoing	O
efforts	O
to	O
characterize	O
novel	O
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
alleles	O
that	O
can	O
undermine	O
the	O
efficacy	O
of	O
first	O
-	O
line	O
antimalarial	B:C0003374
drug	I:C0003374
regimens	O
.	O

Results	O
from	O
our	O
study	O
provide	O
new	O
insights	O
into	O
the	O
complex	O
molecular	I:C4246449
basis	I:C4246449
and	O
physiological	O
impact	O
of	O
PfCRT	O
-	O
mediated	O
antimalarial	O
drug	O
resistance	I:C0013203
,	O
and	O
inform	O
ongoing	O
efforts	O
to	O
characterize	O
novel	O
P.	O
falciparum	I:C0017337
chloroquine	I:C0017337
resistance	I:C0017337
transporter	I:C0017337
alleles	O
that	O
can	O
undermine	O
the	O
efficacy	O
of	O
first	O
-	O
line	O
antimalarial	O
drug	I:C0003374
regimens	B:C0040808
.	O

